Oncolytics Biotech R to Host Conference Call to Discuss CoDevelopment Agreement with Pfizer and Merck KGaA

Oncolytics Biotech (R) to Host Conference Call to Discuss Co-Development Agreement with Pfizer and Merck KGaA

07:08 EDT 5 Jun 2019 | FinanzNachrichten

SAN DIEGO, CA, and CALGARY, AB / ACCESSWIRE / June 5, 2019 / Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, a...

More From BioPortfolio on "Oncolytics Biotech (R) to Host Conference Call to Discuss Co-Development Agreement with Pfizer and Merck KGaA"